JP2004525140A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525140A5
JP2004525140A5 JP2002574969A JP2002574969A JP2004525140A5 JP 2004525140 A5 JP2004525140 A5 JP 2004525140A5 JP 2002574969 A JP2002574969 A JP 2002574969A JP 2002574969 A JP2002574969 A JP 2002574969A JP 2004525140 A5 JP2004525140 A5 JP 2004525140A5
Authority
JP
Japan
Prior art keywords
group
substituted
unsubstituted
cycloalkenylalkyl
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002574969A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525140A (ja
Filing date
Publication date
Priority claimed from CA 2342472 external-priority patent/CA2342472A1/en
Application filed filed Critical
Priority claimed from PCT/AU2002/000339 external-priority patent/WO2002076454A1/en
Publication of JP2004525140A publication Critical patent/JP2004525140A/ja
Publication of JP2004525140A5 publication Critical patent/JP2004525140A5/ja
Pending legal-status Critical Current

Links

JP2002574969A 2001-03-26 2002-03-20 ガンの治療方法及び該治療方法に使用する組成物 Pending JP2004525140A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27843501P 2001-03-26 2001-03-26
CA 2342472 CA2342472A1 (en) 2001-03-30 2001-03-30 Ram having dynamically switchable addressing modes
PCT/AU2002/000339 WO2002076454A1 (en) 2001-03-26 2002-03-20 Method for treatment of cancer and compositions for use therein

Publications (2)

Publication Number Publication Date
JP2004525140A JP2004525140A (ja) 2004-08-19
JP2004525140A5 true JP2004525140A5 (https=) 2006-01-05

Family

ID=25682475

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002574969A Pending JP2004525140A (ja) 2001-03-26 2002-03-20 ガンの治療方法及び該治療方法に使用する組成物

Country Status (4)

Country Link
US (1) US20050038022A1 (https=)
EP (1) EP1379242B1 (https=)
JP (1) JP2004525140A (https=)
WO (1) WO2002076454A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7333701A (en) 2000-07-10 2002-01-21 Univ Texas Chromosome 3p21.3 genes are tumor suppressors
WO2002067932A1 (en) 2001-01-11 2002-09-06 Board Of Regents, The University Of Texas System Antihelminthic drugs as a treatment for hyperproliferative diseases
EP1581217A4 (en) * 2002-11-01 2007-07-11 Merck & Co Inc CARBONYLAMINO-BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF ANDROGENIC RECEPTORS
CA2534649A1 (en) * 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
EP1723138B1 (en) * 2004-02-11 2010-07-14 Basilea Pharmaceutica AG Substituted benzimidazoles and their use for inducing apoptosis
FR2868421B1 (fr) 2004-04-01 2008-08-01 Aventis Pharma Sa Nouveaux benzothiazoles et leur utilisation comme medicaments
CN101035530B (zh) * 2004-08-31 2013-07-03 新南部创新有限公司 Vegf抑制
US20090286838A1 (en) * 2004-12-06 2009-11-19 Newsouth Innovations Pty Limited Treatment for cancer
ZA200705872B (en) * 2005-01-14 2008-09-25 Genelabs Tecnologies Inc Indole derivatives for treating viral infections
TW200720255A (en) * 2005-07-13 2007-06-01 Taiho Pharmaceutical Co Ltd Benzoimidazole compound capable of inhibiting prostaglandin d synthetase
PE20070335A1 (es) 2005-08-30 2007-04-21 Novartis Ag Benzimidazoles sustituidos y metodos para su preparacion
FR2891273B1 (fr) 2005-09-27 2007-11-23 Aventis Pharma Sa NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
WO2009043093A1 (en) * 2007-10-04 2009-04-09 Newsouth Innovations Pty Limited Hif inhibition
US8835506B2 (en) 2008-06-05 2014-09-16 Stc.Unm Methods and related compositions for the treatment of cancer
EP2432451A2 (en) * 2009-05-20 2012-03-28 Children's Medical Center Corporation Compositions for the treatment of metastatic cancer and methods of use thereof
US8895596B2 (en) 2010-02-25 2014-11-25 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
US11028055B2 (en) 2015-11-30 2021-06-08 Children's Medical Center Corporation Compounds for treating proliferative diseases
JP2018002619A (ja) * 2016-06-29 2018-01-11 国立大学法人 東京大学 オートファジー阻害剤
GB2559162A (en) * 2017-01-27 2018-08-01 Univ Bradford Compound for use in medicine
TW202214244A (zh) * 2020-08-10 2022-04-16 國立彰化師範大學 具有協同抗癌功效之氯硝柳胺（Ｎｉｃｌｏｓａｍｉｄｅ）和雙硫侖（Ｄｉｓｕｌｆｉｒａｍ）醫藥組合物及其用途
CN113648308A (zh) * 2021-09-14 2021-11-16 东莞市人民医院 奥芬达唑作为抗卵巢癌药物的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
AUPO727097A0 (en) * 1997-06-10 1997-07-03 Unisearch Limited Method of treatment of hepatoma and pharmaceutical compositions for use therein
AUPP332898A0 (en) * 1998-05-04 1998-05-28 Unisearch Limited Pharmaceutical composition
US6287602B1 (en) * 1998-09-16 2001-09-11 Oncopharmaceutical, Inc. Treatment of oncologic tumors with an injectable formulation of a Golgi apparatus disturbing agent
GB9900752D0 (en) * 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
US6423734B1 (en) * 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
PT1214052E (pt) * 1999-09-03 2004-12-31 Janssen Pharmaceutica Nv Formulacao veterinaria para a administracao de um medicamento insoluvel em agua a um animal visado, atraves de um sistema de distribuicao de agua
US6693125B2 (en) * 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders

Similar Documents

Publication Publication Date Title
JP2004525140A5 (https=)
TWI385160B (zh) 用於治療增生性疾病的化合物
US9175022B2 (en) Compounds for the treatment of proliferative disorders
ES2399241T3 (es) Compuestos de triazol que modulan la actividad de HSP90
US8188075B2 (en) Triazole compounds that modulate HSP90 activity
JP2007520452A5 (https=)
JP2019507114A5 (https=)
US8399435B2 (en) Compounds for the treatment of proliferative disorders
JPWO2020163823A5 (https=)
JPWO2020173935A5 (https=)
WO2008033449A2 (en) Compounds for the treatment of angiogenesis
JP2021523169A5 (https=)
JP2006503805A5 (https=)
WO2018158175A1 (en) Combination of bub1 inhibitors
JP2003535874A5 (https=)
RU2005108570A (ru) Лекарственное средство для лечения доброкачественных и злокачественных опухолевых заболеваний, содержащее производное дисоразола
JP2019529563A5 (https=)
RU2024139605A (ru) Соединения пиридо[4,3-d]пиримидина
JPWO2023107606A5 (https=)
JPWO2020124059A5 (https=)
JPWO2021026450A5 (https=)
JP2008512497A5 (https=)